These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 33823148

  • 1. Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat.
    Gore A, Neufeld-Cohen A, Egoz I, Baranes S, Gez R, Efrati R, David T, Dekel Jaoui H, Yampolsky M, Grauer E, Chapman S, Lazar S.
    Toxicol Appl Pharmacol; 2021 May 15; 419():115519. PubMed ID: 33823148
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a combined anti-seizure treatment against cholinergic established status epilepticus following a sarin nerve agent insult in rats.
    Lazar S, Neufeld-Cohen A, Egoz I, Baranes S, Gez R, Glick P, Cohen M, Gutman H, Chapman S, Gore A.
    Toxicol Appl Pharmacol; 2024 Mar 15; 484():116870. PubMed ID: 38395364
    [Abstract] [Full Text] [Related]

  • 3. Sarin-induced brain damage in rats is attenuated by delayed administration of midazolam.
    Chapman S, Yaakov G, Egoz I, Rabinovitz I, Raveh L, Kadar T, Gilat E, Grauer E.
    Neurotoxicology; 2015 Jul 15; 49():132-8. PubMed ID: 25976749
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of retigabine in ameliorating the brain insult following sarin exposure in the rat.
    Gore A, Neufeld-Cohen A, Egoz I, Baranes S, Gez R, Grauer E, Chapman S, Lazar S.
    Toxicol Appl Pharmacol; 2020 May 15; 395():114963. PubMed ID: 32209366
    [Abstract] [Full Text] [Related]

  • 5. Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.
    Loughery TN, Whitten KA, Acon-Chen C, Shih TM.
    Toxicol Appl Pharmacol; 2021 May 15; 419():115515. PubMed ID: 33798593
    [Abstract] [Full Text] [Related]

  • 6. Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes.
    Lewine JD, Weber W, Gigliotti A, McDonald JD, Doyle-Eisele M, Bangera N, Paulson K, Magcalas C, Hamilton DA, Garcia E, Raulli R, Laney J.
    Neurotoxicology; 2018 Dec 15; 69():37-46. PubMed ID: 30172622
    [Abstract] [Full Text] [Related]

  • 7. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J, Lumley L, Baldwin R, Rossetti F, Schultz M, de Araujo Furtado M, Suchomelova L, Naylor D, Franco-Estrada I, Wasterlain CG.
    Epilepsy Behav; 2019 Dec 15; 101(Pt B):106367. PubMed ID: 31636007
    [Abstract] [Full Text] [Related]

  • 8. Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
    Niquet J, Baldwin R, Norman K, Suchomelova L, Lumley L, Wasterlain CG.
    Epilepsia; 2016 Sep 15; 57(9):1406-15. PubMed ID: 27500978
    [Abstract] [Full Text] [Related]

  • 9. Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats.
    Gilat E, Kadar T, Levy A, Rabinovitz I, Cohen G, Kapon Y, Sahar R, Brandeis R.
    Toxicol Appl Pharmacol; 2005 Nov 15; 209(1):74-85. PubMed ID: 16271623
    [Abstract] [Full Text] [Related]

  • 10. Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice.
    Marrero-Rosado BM, de Araujo Furtado M, Kundrick ER, Walker KA, Stone MF, Schultz CR, Nguyen DA, Lumley LA.
    Epilepsy Behav; 2020 Oct 15; 111():107229. PubMed ID: 32575012
    [Abstract] [Full Text] [Related]

  • 11. Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.
    Wu X, Kuruba R, Reddy DS.
    J Pharmacol Exp Ther; 2018 Nov 15; 367(2):302-321. PubMed ID: 30115757
    [Abstract] [Full Text] [Related]

  • 12. Midazolam and isoflurane combination reduces late brain damage in the paraoxon-induced status epilepticus rat model.
    Swissa E, Bar-Klein G, Serlin Y, Weissberg I, Kamintsky L, Eisenkraft A, Statlender L, Shrot S, Rosman Y, Prager O, Friedman A.
    Neurotoxicology; 2020 May 15; 78():99-105. PubMed ID: 32084435
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats.
    Lumley LA, Nguyen DA, de Araujo Furtado M, Niquet J, Linz EO, Schultz CR, Stone MF, Wasterlain CG.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):347-357. PubMed ID: 37977809
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
    Nguyen DA, Stone MF, Schultz CR, de Araujo Furtado M, Niquet J, Wasterlain CG, Lumley LA.
    J Pharmacol Exp Ther; 2024 Jan 17; 388(2):376-385. PubMed ID: 37770198
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.